Fair Pharmaceutical Pricing

340 B: Current Status

Tue, 13 Jul 2010 13:25:58 GMT

Find out the status of legislative activity.

340 B Program Overview

Thu, 28 Jan 2010 16:16:38 GMT

1/20/10 - Maximizing the 340B Drug Discount Program: A Webinar for Finance Executives in 340B Hospitals

Fri, 05 Mar 2010 13:21:32 GMT

Safety Net Hospitals for Pharmaceutical Access (SNHPA) and the National Association of Public Hospital and Health Systems (NAPH) hosted a complimentary webinar for CFOs and other finance executives to learn more about maximizing cost-savings through the 340B drug discount program.

Speakers: Bill von Oehsen, President and General Counsel, SNHPA

Petra Fippen, Manager of Pharmacy Inventory, Contracting and Patient Assistance Programs, Wishard Health Services

Our View: Extend the 340B Drug Discount Program to the Inpatient Setting in Health Reform (Dec. 24, 2009)

Wed, 23 Dec 2009 16:21:54 GMT

The 340B drug discount program provides discounted outpatient drugs to safety net providers. Health reform legislation currently in the Senate extends these discounts to the inpatient setting. Our View outlines why these savings should extend to the inpatient setting in the final health care bill.

7/2/2009: Nuts and Bolts of the 340B Drug Discount Program

Wed, 03 Feb 2010 16:16:58 GMT

This presentation describes 340B compliance and opportunities for savings. It covers guidelines and regulations concerning inventory management, Medicaid billing and contract pharmacies.

Safety Net Hospitals for Pharmaceutical Access

Mon, 15 Jun 2009 16:53:57 GMT

Safety Net Hospitals for Pharmaceutical Access (SNHPA) began as an NAPH initiative to increase the affordability and accessibility of pharmaceutical care for the nation's poor and underserved populations. SNHPA is now an organization of over 500 public and private non-profit hospitals and health systems throughout the U.S. that participate in the Public Health Service 340B drug discount program. SNHPA is dedicated to educating its members and others about the 340B program and creating new opportunities for members to save on pharmaceuticals and improve access to pharmaceutical care for vulnerable populations.